Instruments
and Solutions for Oligonucleotide Purity Analysis Oligonucleotide
therapeutics are revolutionizing treatments for various diseases, increasing
the demand for precision in oligo synthesis and purity analysis. Well-structured
workflows for oligonucleotide purity analysis are essential to meet the
rigorous quality standards required for successful downstream applications and
eventual manufacturing scale-up. Challenges
in Oligonucleotide Synthesis Producing
high-quality oligos involves addressing specific challenges, such as achieving
consistent purity and minimizing sequence-related impurities. The presence of
failed sequences or other impurities can compromise the efficacy and stability
of synthesized oligonucleotides, affecting their performance in research and
therapeutic applications. Instruments
and Technologies for Streamlined Workflows Modern
advancements in oligo synthesis instruments support each step of the
workflow—from sample preparation and separation to detection and final
analysis. Precision instruments optimize processes such as: Agilent
offers a full suite of instruments designed for every stage of the
oligonucleotide synthesis and purity analysis workflow. Whether conducting
routine purity checks or performing detailed target plus impurity analyses,
Agilent’s technologies provide accurate, reliable results to meet the demands
of oligonucleotide research and manufacturing.